# EDGAR Filing Document

**Accession Number:** 0001958713
**File Stem:** 0000000000-25-006832
**Filing Date:** 2025-6
**Character Count:** 6366
**Document Hash:** 32627017d81730e494d9ad6e2c51c561
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-006832.hdr.sgml**: 20260611

**ACCESSION NUMBER**: 0000000000-25-006832

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250630

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NFT Ltd
- **CENTRAL INDEX KEY:** 0001958713
- **STANDARD INDUSTRIAL CLASSIFICATION:** FINANCE SERVICES [6199]
- **ORGANIZATION NAME:** 09 Crypto Assets
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-288243

**BUSINESS ADDRESS:**
- **STREET 1:** OFFICE Q 11TH FLOOR, KINGS WING PLAZA 2
- **STREET 2:** NO. 1 KWAN ST., SHA TIN, NEW TERRITORIES
- **CITY:** HONG KONG
- **STATE:** K3
- **ZIP:** 999077
- **BUSINESS PHONE:** 86-13020144962

**MAIL ADDRESS:**
- **STREET 1:** OFFICE Q 11TH FLOOR, KINGS WING PLAZA 2
- **STREET 2:** NO. 1 KWAN ST., SHA TIN, NEW TERRITORIES
- **CITY:** HONG KONG
- **STATE:** K3
- **ZIP:** 999077
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001213900-25-056766

## Text-Extract

```

                                                            June 30, 2025

Kuangtao Wang
Chief Executive Officer and Chairman
NFT Limited
Office Q 11th Floor, Kings Wing Plaza 2,
No.1 Kwan Street, Sha Tin, New Territories
Hong Kong

       Re: NFT Limited
           Registration Statement on Form F-1
           Filed June 23, 2025
           File No. 333-288243
Dear Kuangtao Wang:

       We have conducted a limited review of your registration statement and
have the
following comments.

        Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe a comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments.

Registration Statement on Form F-1
General

1.     We note you are registering for resale 9,253,262 shares of Class A
ordinary shares.
       Given the size of the offering relative to the number of shares
outstanding, please
       provide us with a detailed analysis as to why you believe the
transaction is
       appropriately characterized as a secondary offering that is eligible to
be made
       under Rule 415(a)(1)(i), rather than a primary offering in which the
selling
       shareholder is actually an underwriter selling on your behalf. For
guidance, please see
       Question 612.09 of the Division   s Securities Act Rules Compliance &
Disclosure
       Interpretations.
 June 30, 2025
Page 2
Cover Page

2.     We note your disclosure on the cover page that the Trial Measures impose
certain
       filing requirements for direct and indirect overseas listings and
offerings. Please
       disclose how, if at all, the Trial Measures apply to you and any
offerings of your
       securities. In addition, please disclose how you reached this conclusion
regarding the
       Trial Measures, including whether you are relying on the advice of
counsel. If you
       relied on the advice of counsel, you should identify counsel and file
the consent of
       counsel as an exhibit to your registration statement. If you did not
rely on the consent
       of counsel, you should explain how you reached your conclusion regarding
whether
       the Trial Measures apply to you. Finally, please discuss the
consequences of non-
       compliance with the Trial Measures, including potential fines and other
impacts.
3.     We note your disclosure on the cover page of how cash is transferred
through your
       organization. Please revise to include a cross-reference to the
consolidated financial
       statements. In addition, in your prospectus summary, please describe
your written
       cash management policies and procedures that dictate how funds are
transferred (e.g.,
       a policy that addresses how a company handles any limitations on cash
transfers due
       to PRC law).
Risk Factors
Risks Related to Doing Business in Hong Kong, page 24

4.     Please revise to remove the the introductory paragraph to this section
on page 24.
       Similarly, please revise your disclosure on apge 35 that "[i]t it is
possible that all the
       legal and operational risks associated with being based in and having
operations in the
       PRC may also apply to operations in Hong Kong in the future" to clarify
that the legal
       and operational risks associated with having operations in the PRC apply
to having
       operations in Hong Kong.
Selling Shareholder, page 38

5.     Please identify any natural persons who have or share voting and/or
dispositive power
       with respect to the shares owned by the entities listed in your table of
selling
       shareholders.
Plan of Distribution, page 44

6.     We note your disclosure that the Selling Shareholders may sell their
ordinary shares
       through purchases by a broker-dealer as principal and resale by the
broker-dealer for
       its account. Please confirm your understanding that the retention by a
Selling
       Shareholder of an underwriter would constitute a material change to your
plan of
       distribution requiring a post-effective amendment. Refer to your
undertaking provided
       pursuant to Item 512(a)(1)(iii) of Regulation S-K.
 June 30, 2025
Page 3

        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence
of action by the staff.

       Refer to Rules 460 and 461 regarding requests for acceleration. Please
allow adequate
time for us to review any amendment prior to the requested effective date of
the registration
statement.

       Please contact Irene Paik at 202-551-6553 or Sonia Bednarowski at
202-551-3666
with any questions.

                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of Crypto
Assets
cc:   Joan Wu, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._